ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001076.1|Liposidomycin_1 # 1 # 1176 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.661	BGC0001076.1|Liposidomycin_1 	1	1176	-	Loose	300	26.5646	poxtA	27.66	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGGCAGCGGATTGCGCCATAGGAATTCACGATCTGTCATTCGCGACAACCGAGTTCGTCCTGCCGCATACGGCACTCGCAGAACACAACGGCACCGAGATCGGCAAATACCATGTGGGCATCGGCCAGCGGTCGATGAGCGTGCCCGGCGCCGACGAGGACATCGTGACCATGGGCGCGGCCGCTGCCGAACCGATCATCGCCCGGCACGGCCGCGGTCGGATCCGGACAGTCGTGTTCGCGACGGAGTCGTCGATCGACCAGGCGAAATCGGCCGGTGTGTACGTCCATTCGCTGCTCGGGTTGCCGTCGGCCACCAGGGTCGTCGAGCTGAAGCAAGCCTGCTACGGCGCCACGGCGGCCCTGCAGTTCGCCGTCGGCCTCGTGTTGCGTGACCCCGCCCAGCAGGTCCTCGTGGTCGCGAGCGACATCTCCAAGTACGACCTGGAAAGCCCTGGCGAGGCGACACAGGGCGCGGCGGCGGTGGCCATGCTGGTCTGCTCGGATCCTGCGCTGGTACGTATCGAGGAACCTTCAGGTCTGTTCACCTCCGACGTCATGGACTTCTGGCGGCCGAACTACCGTGACGCCGCACTGGTCGACGGCGAGGGGTCCATCACCGCGTATCTGCAGGCGGTGGAGAGCAGTTGGAAGGATTACACGGAGCAGGGCGGGCGCTCGCTCGACGAGTTCACCGCGTTCTGCTATCACCAGCCGTACACGAAGATGGCTTACAAAGCGCACCGCCACCTGCTCAACACCTGTGCGTACGACACCGACGAGGCTCGGATCAGTCGAGCCGTCGAACCGACCACGGCCTACAACATGGTCATCGGCAACAGCTACACCGCGTCGACGTACCTCGGCCTCGCCTCGCTGCTGGACCGGGCCGACGACCTGCCCGGACGGCCGATCGGGTTTCTCAGCTACGGCTCCGGCAGCGTTGCCGAATTCTTCGCCGGAACCGTCGTTCCCGGCTACCGGGAGCACCTGCGGACGCCGGCACACCACGAGGCGATCGGCCGACGGCGGCCACTCGACTATGCCGCCTACCGCGAGCTGCATGAACGGTCCTTCCCAACGGACGGCGGCGACCACCCGACTCCGTCGCAGACCACCGGACCCTATCGACTGGCAGCTCTGCGCGGCCACAAGCGCGTCTACGAGAGGTGCTAG	MAADCAIGIHDLSFATTEFVLPHTALAEHNGTEIGKYHVGIGQRSMSVPGADEDIVTMGAAAAEPIIARHGRGRIRTVVFATESSIDQAKSAGVYVHSLLGLPSATRVVELKQACYGATAALQFAVGLVLRDPAQQVLVVASDISKYDLESPGEATQGAAAVAMLVCSDPALVRIEEPSGLFTSDVMDFWRPNYRDAALVDGEGSITAYLQAVESSWKDYTEQGGRSLDEFTAFCYHQPYTKMAYKAHRHLLNTCAYDTDEARISRAVEPTTAYNMVIGNSYTASTYLGLASLLDRADDLPGRPIGFLSYGSGSVAEFFAGTVVPGYREHLRTPAHHEAIGRRRPLDYAAYRELHERSFPTDGGDHPTPSQTTGPYRLAALRGHKRVYERC	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	72.14	gnl|BL_ORD_ID|2510|hsp_num:0	2904			489	630	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
BGC0001076.1|Liposidomycin_2 # 1229 # 2431 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGGA;rbs_spacer=6bp;gc_cont=0.670	BGC0001076.1|Liposidomycin_2 	1229	2431	-	Loose	525	26.5646	OKP-D-1	48.39	3006153	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OKP beta-lactamase	ATGATCGCGGCATCGACCACTCTCGCACCTGCCGCGACGGCGGCGGAGACACCGAAGCCGACCTTCCCCATCGGCGGGCTCTGGTACACGGTCAAGGTCCCCGAGTCCGGTCATGACAACGAGCGCGTGTTCTACACCGCGTCGCTCCCCGCCGTGCTGCCCAAGGAACTGTCCGCCATCCTGTCCGCGTTACCGCCGTTCCGGCCGGCGAACGTCATCGCCGACAAGTCCGGCCACGAGATATGGCGGTACTCACCGCCCATCGGCCAGAACGTCGCCGACTTCCGCAAGCAGACGTACCACGGCAAGCCGGTCCTCACCTGGTGGCAGGGCGTCGAGAAGGGCGGCTACGGCTCAGGAGTGGGCTACATCGCGGACGAGAACCACCACGTCATCAAGACCGTGTCCCCTGGAGGCGGACTCGCCGCGGACGAGCACGAGTTCCGTCTGACCTCCGACGGCCGGGCGCTGATCACCAGCTATCACGAGGTCACCGCCGACCTCACCTCGATCGGCGGTCCGGCCGACGGGAAGGTGCTCGACGCGGTTGCCTCGATCGTCGATGTGGACAGCGGACGGACCCTGTTCCGCTGGAGCGCCCTCGATCATGTGCCGCTCACCGAGACCCAGATGCCCGAGTTGCTGTCGGGACAGACCGCGTACGACCCGTACCACATCAACTCGATGTCACTGTCCCCGAACGGTGACCTGATCGTCTCGCTGCGGAACACGTCCACGGTCTACAGCATCGACACCGGCACCGGCACCGGCACCGGCACCGGCACCGGCGAGATCAACTGGAAGCTCGGCGGGAAGAATTCCACCCTTGCGCTGGGCCCGGGCATCGAGTTCGCATTCCAGCACGACGCCGAAGCCGTCGATGCGCACACCGTCCGGCTCTTCAACAACAACTCCTCGAACATGAACTCCGCACAGGGCCGCTCCAGCGTCGAGTGGGTCCGCGTCGACCCCGTGGCCAAGACCGCGACGCTGGTCCGCAACCAGGTTCATCCCGACGGCATGACGGCCTTCGCAATGGGCAACGCGGAGGCCCTGCCCGGCGGCGACACGGCGGTCAGCTGGGGCACCGCTCCCCGGATCTCGAAATTCTCGCCGAGCGGCGCCCTGCTCTACGACGCCTCGCTCCCGTTCGGTACCTACCGCGCCTACTTCGCCGACTGGCCAGACACCTCGTCCCGGTAG	MIAASTTLAPAATAAETPKPTFPIGGLWYTVKVPESGHDNERVFYTASLPAVLPKELSAILSALPPFRPANVIADKSGHEIWRYSPPIGQNVADFRKQTYHGKPVLTWWQGVEKGGYGSGVGYIADENHHVIKTVSPGGGLAADEHEFRLTSDGRALITSYHEVTADLTSIGGPADGKVLDAVASIVDVDSGRTLFRWSALDHVPLTETQMPELLSGQTAYDPYHINSMSLSPNGDLIVSLRNTSTVYSIDTGTGTGTGTGTGEINWKLGGKNSTLALGPGIEFAFQHDAEAVDAHTVRLFNNNSSNMNSAQGRSSVEWVRVDPVAKTATLVRNQVHPDGMTAFAMGNAEALPGGDTAVSWGTAPRISKFSPSGALLYDASLPFGTYRAYFADWPDTSSR	MRYVHLCVISLFACLPLPLFAGPQPLEQIKISESQLSGRVGYVEMDLASGRTLAAWRADERFPLTSTFKVLLCGAVLARVDAGVERLDRRIHYRQQDLVAYSPVSEKHLADGMTVGELCAAAITMSDNSAGNLLLDTLGGPAGLTAFLRTIGDNVTRLDRRETQLNEALPGDVRDTTTPASMAATLRKLLTAKHLSARSQQQLVQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARGIVALLGPDGKAERIVVIYMRDTPATIAERNQQIAAIGAALIEHWQR	139.86	gnl|BL_ORD_ID|3724|hsp_num:0	4794			132	222	
BGC0001076.1|Liposidomycin_3 # 2531 # 3376 # -1 # ID=1_3;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.673	BGC0001076.1|Liposidomycin_3 	2531	3376	-	Loose	450	33.113	aadA16	30.7	3002616	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	TTGACTTCTCCGCGCGGGATCGATCCCGGTCAGGAACCGTGGATTCTCGCCCAGCGTTTCGCGAATCGACTGACTGACACTCTGGGCGACATTCTCAGCGATGTCGTGGTGGTGGGATCCGCATCGCTCGGCGACTGGCAGGCGAACAGCGACATCGACCTCGTCTGCATGGTGGAGAGTGAATTGGATTCGCGGGCACGCGAGGCCGTCTCAGCGTTGCACGGGAACTCCAAGGACGAATACGGTCACACGATCGATGCGATGTACGTGACGAAAGACGGCCTGGCCAAGGGCCCCGACCACATCCCGTCCGTCGTGGCGTCGGTCGCCGGAATCCTGCAGCCCGAGTCCACCGACGGACCGCTGAACTGGGCGACCTGGCTCAACATCGTCCAGTCCGGTGTCCGCGTCCCCCTCACCGAGGATGCGGCTCTGACAGCGGTCGGCTCCGCGAGCGACGGGATCCCGATCGAGGAGGCGGCCGCACGCGACGGGGCGATCAGGTTCTCCCGCGCCAATCTGGACCAGTACTGGCGCAACAGGATCGGCCTGTCCGAACAGATCTACCTGCTCCCCGAGACACCCCACCCGGTGTCCGACTTCGAGATCGAGTGGATGTCCCTGGGGCCGGCCCGTCTGCTGGCGACGGTCCTCACCGGGCGCATCGTCTCGAAGTCGGAGGGCGGCGAGCTGGCCGCCGACCGGTTCCCGGAGTTCCGGCCGCACCTCACGGCGGTGCTCGACTCCCGCCGGGGGTCGGACGCCACACGGACATGGGACCGCGGCGACCTGGAGCGTTCGCTCGATCTCGCCCGCATCTGCGTGCGCCTGGGCGCGGAGGACTAG	MTSPRGIDPGQEPWILAQRFANRLTDTLGDILSDVVVVGSASLGDWQANSDIDLVCMVESELDSRAREAVSALHGNSKDEYGHTIDAMYVTKDGLAKGPDHIPSVVASVAGILQPESTDGPLNWATWLNIVQSGVRVPLTEDAALTAVGSASDGIPIEEAAARDGAIRFSRANLDQYWRNRIGLSEQIYLLPETPHPVSDFEIEWMSLGPARLLATVLTGRIVSKSEGGELAADRFPEFRPHLTAVLDSRRGSDATRTWDRGDLERSLDLARICVRLGAED	MSNAVPAEISVQLSQALNVIERHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDETVRQALFVDFLEVSASPGQSEALRALEVTIVVYGDVAPWRYLARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKARQHSLALAGSAAEDFFNSVPESDLFKALADTLKLWNSQPDWAGDERNVVLTLSRIWYSAATGKIAPKDVAANWVMERLPVQHQPVLLEAQQAYLGQGMDCLASRADQLTAFIYFVKHEAASLLGSTPMMSNSSFKPTPLRGAA	100.00	gnl|BL_ORD_ID|1615|hsp_num:0	1762			51	384	spectinomycin; streptomycin
BGC0001076.1|Liposidomycin_4 # 3703 # 4752 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=4bp;gc_cont=0.692	BGC0001076.1|Liposidomycin_4 	3703	4752	+	Loose	960	27.335	cmeC	33.33	3000785	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGTTCACGTCACAAAACCGGTCACCGTGCTGGCCGGTCACAAGGTCACCACACAGGAGATCTGCGCCGAGATCCGCACACGGATGCCGGAGCATCCACGGCTGGGGGCGTTCCTTCGGTCGATGGGCGGCTGCGGCGTTGACACAAGGTACTTCAGCCGCCCCTTCGCCGAGGTCGTCGAGGACGTCGGAGTCGCCAGCCGCAACCGAACCGCGTTCGCGGACGCCCGCTCCATGGCCGTCGCCGCCGCCCGCCGTGCATTGGCGGCGGTCGGCCTGGCCTCCGGTGACATCGATGCCATAGTCGCCAGCCACACGACCTCGTGGACGGTGCCGGGCCTGGACGTCCACCTCGTCGAGGCGCTCGGTCTCCGCCCGGACGTGTCCCGCGTCGCTCTCACGTCGTCGGCGTGCGCGGGCGGGACACAAGCTCTCATCCGGGCGGCTGACCAGCTCGCGGCGCGGCCCGGCGGCAAGGTCCTCGTGGTGGTGGCGGAAGCGCTGTCCACCATCTACCACGCGCACGAGGACAACATCGAAAGCATGATCTACAAGGTGCTGTTCGGCGACTCCGCGGGCGCCTGCGTGGTCACTGACGTGCCACTGGAGTCGGGTTTCGCCATCGAGTCCGCCTTCGAGTACGTCCTGCCGAACTCGCTGGACCGCTACTGGAGCGAGGTGGATGCCGCCGGCGTGCACTTCAGGTCGACGAGGAAGGCTCTCGGCGCTCCCAAGGAGGTGCTTCCGGCGGTTCTGGGCTGGCTGGGGTCCTGGCGCCCCGAGTTCGCCGTGATACACCCCGGCGGGCCGCGCATCATCTCCGAGGTCGCCGCGGCGCTGGGACTCGGCGAGCAGGATGCCGGGCATTCGTTCGCCTCGCTGGAGGAGAACGGCAACCTCGGCGGCAACGCGGTGCTGGACGTGCTCGGTCGCAACCATGCGACGCCCCCTCCGGACGGAGCCGAAGGACTCATCGTCGCCTTCGGGCCCGGGTTCTCCGCCGCCTGTGTGCGTGGAGTGTGGCGTGCGCCGACTGCAGAAAGGTGA	MPVHVTKPVTVLAGHKVTTQEICAEIRTRMPEHPRLGAFLRSMGGCGVDTRYFSRPFAEVVEDVGVASRNRTAFADARSMAVAAARRALAAVGLASGDIDAIVASHTTSWTVPGLDVHLVEALGLRPDVSRVALTSSACAGGTQALIRAADQLAARPGGKVLVVVAEALSTIYHAHEDNIESMIYKVLFGDSAGACVVTDVPLESGFAIESAFEYVLPNSLDRYWSEVDAAGVHFRSTRKALGAPKEVLPAVLGWLGSWRPEFAVIHPGGPRIISEVAAALGLGEQDAGHSFASLEENGNLGGNAVLDVLGRNHATPPPDGAEGLIVAFGPGFSAACVRGVWRAPTAER	MNKIISISAIASFTLLISACSLSPNLNIPEANYSIDNKLGALSWEKENNSSITKNWWKDFDDENLNKVVDLALKNNNDLKLAFIHMEQAAAQLGIDFSSLLPKFDGSASGSRAKTAINAPSNRTGEVSYGNDFKMGLNLSYEIDLWGKYRDTYRASKSSFKASEYDYEAARLSVISNTVQTYFNLVNAYENENALKEAYESAKEIYRINDEKFQVGAVGEYELAQARANLESMALQYNEAKLNKENYLKALKILTSNDLNDILYKNQSYQVFNLKEFDIPTGISSTILLQRPDIGSSLEKLTQQNYLVGVARTAFLPSLSLTGLLGFESGDLDTLVKGGSKTWNIGGNFTLPIFHWGEIYQNVNLAKLNKDEAFVNYQNTLITAFGEIRYALVARKTIRLQYDNAQASEQSYKRIYEIAKERYDIGEMSLQDYLEARQNWLNAAVAFNNTKYSYANSIIDVIKAFGGGFEQSEDTSKNIKEESKNLDMSFRE	70.93	gnl|BL_ORD_ID|731|hsp_num:0	798			921	1041	erythromycin; cefotaxime; fusidic acid
BGC0001076.1|Liposidomycin_5 # 4802 # 5539 # 1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=AGTGA;rbs_spacer=13bp;gc_cont=0.738	BGC0001076.1|Liposidomycin_5 	4802	5539	+	Loose	1900	28.4906	MexI	48.0	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGGCGAAGGCCGCCGGGCGAGTGCTGCTGGCTCTCCGTGAGGAGACCGGTTTCGCCGACCCGGGGGCGCTGCGCGCACTCGGCGACCGGCGCTCGCACGAGTACCTGGCGGCAGAGCTCGAACGACACCGCCCTGACGATGCGGTCCTCTCCGAGGAGGGGGCCGACGACGTCGGACGCCTGACCCGCTCGCGTGTCTGGATCATCGACCCGTTGGACGGGACACGGGAGTACGCCGAGCCCGCCCGGACCGACTGGGCAGTGCACGTCGGCCTGTGGCAGAGCGGTGAACTCGCCGCCGGTGCCGTGGCGATGCCGGCCCGGGATCTCGTGCTGAGCACGACCGGGGTGAAGCCGGCGGAGCCGAGGCCCACCGGTCGCGGCGGCCTGCGGCTGGCCGTGAGCAGGACCAGGCCGCCCGCCCTGGCGCGGCAGTTGGCGAAGACGCTCGACGCCGAGCTCGTGCCGATGGGTTCGGCCGGCGTGAAGATCGGCGCGGTCGTGCTCGGCGAGGTGGACGCCTACGTCCACGGCGGCGGGCAGTACGAATGGGACTCCGCGGCTCCGGTCGCCGTGGCCCGGGCGGCCGGGTGCCACGCCTCGCGGCTCGACGGCCGCGCACTGGCCTACAACCAGCCAGATGCCTGGCTGCCGGATCTGGTGGTGTGCCGGCCCGAACTCCGGGGCCGTCTGCTCCCGGCGATCCTGGCGGCCACCGCAGCAGAGAGGACGTCATGA	MAKAAGRVLLALREETGFADPGALRALGDRRSHEYLAAELERHRPDDAVLSEEGADDVGRLTRSRVWIIDPLDGTREYAEPARTDWAVHVGLWQSGELAAGAVAMPARDLVLSTTGVKPAEPRPTGRGGLRLAVSRTRPPALARQLAKTLDAELVPMGSAGVKIGAVVLGEVDAYVHGGGQYEWDSAAPVAVARAAGCHASRLDGRALAYNQPDAWLPDLVVCRPELRGRLLPAILAATAAERTS	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	23.81	gnl|BL_ORD_ID|4683|hsp_num:0	1647			2259	2334	acriflavine; tetracycline; norfloxacin
BGC0001076.1|Liposidomycin_6 # 5536 # 6174 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGAGA;rbs_spacer=7bp;gc_cont=0.681	BGC0001076.1|Liposidomycin_6 	5536	6174	+	Loose	600	26.1794	CfxA6	26.17	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGAAGATCATCGGGGCCGGTTTCGGACGCACCGGAACGCTGTCGGTGAAAGCAGCCCTGGAGACGCTCGGTCTCGGGCCGTGCTACCACATGCTGACCGCCTTCGAGGAGCCCGGACACCTGAGCCTGTGGAATGCCGTCGGCCGGGGCGAGCGGGCCGACTGGGCCCAGCTCTTCGCCGGATACCGGTCCACCGTGGACTGGCCGGCGTGCGACCACTGGGAGACGCTGGCACGGGAGTACCCGGACGCGAAGATCCTGCTGACGGTGCGGGACCCCGCCCGGTGGTACGACAGCTTCAGCGAGACGCTGGCGCCGCTGTGGTCGGTCGAGTCCGACGACCCCGAGCTGCGCGAGTACCTCGAACTCGTCCGGCGCATCACCGTGCGCACCTTCGGCGGACGGCTCGATGACCGGGCGCATGCCATCGCCGTGTTCGAGGAGCACAACCGTAAGGTACGCGCCGCGATTCCGGCCCAACGATTGCTCGTCTACGACGTCCGGGAGGGATGGGAGCCGTTGAGCACGTTCTTCGGCAGGCCGGTGCCGTCGGACACGGCCTTTCCCCATCTCAACGACCGGGCGAAATTCCAGGAGTTGCTCCAGAGCCGTCTGGCCCACCGCGGCGACCCGAGATGA	MKIIGAGFGRTGTLSVKAALETLGLGPCYHMLTAFEEPGHLSLWNAVGRGERADWAQLFAGYRSTVDWPACDHWETLAREYPDAKILLTVRDPARWYDSFSETLAPLWSVESDDPELREYLELVRRITVRTFGGRLDDRAHAIAVFEEHNRKVRAAIPAQRLLVYDVREGWEPLSTFFGRPVPSDTAFPHLNDRAKFQELLQSRLAHRGDPR	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	64.05	gnl|BL_ORD_ID|240|hsp_num:0	268			180	486	
BGC0001076.1|Liposidomycin_7 # 6677 # 7444 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.689	BGC0001076.1|Liposidomycin_7 	6677	7444	+	Loose	230	50.0618	ramA	32.08	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	GTGCTGGAGGCCGATCCCGGGCAGCACGCCCTCGTTCTCAGTTCCCAGGGCGAGATCAGCGTGGCGCGTGACGAGCGTGAACTCCTCGTCCGGGGCGAGGCGGTGGCGCTGTGCGACACCCGGCTCCCGCTGGGCATCAGCCCGACACCCAGAAACCCCACGGCCGAGGCGGTCGTGATGGTCTTCCCCGGCGCGGCGGTGCCGACGGCCTCACCGGACACCGACGCATCGCAGCACAAGGTCTGCGATGCCGCGGGTTCGGGGGCGCTGCTGCGCTCGTTCCTGATCGAGGCCGCCGGCCGGGCGAGCGGACTGGGCGCACCCGAGGTGGCTCGGTTCGGCGATGCCGCGCTGCACCTGGCCGCGGCAGTGCTGGAGCGGCACTTCACCGACGCCGACGAAGCCGGCCCGCAGACCGAGCAGCACGAGCTGCTGACGCGCATTCGCGGATTCATCGACCGCAACCTCGGTGAGCCGGACCTGTCGCCGAGCCTGGTCGCCTCGGCCCACCACATCTCCATTCGCTACCTGCAGCGGCTGTTCAAGACGGAGGGCAGTACACCCTCGGATTGGATCCGGCAGCGGAGACTTGAGAACAGCCGACGTGAACTCTGCGACGCGAAGCTGCGATCGGCTTCGATCCGTGAGATCGGCCTGCGCAACGGTTTTGCCCAGCCCTCCGACTTCAGTCGGGTATTCCGTGCCAATTACGGCATACCGCCGGGCAAGTTTCGGGACGACTGGTTCCGGCGGGACGCGGTCGGCTAA	MLEADPGQHALVLSSQGEISVARDERELLVRGEAVALCDTRLPLGISPTPRNPTAEAVVMVFPGAAVPTASPDTDASQHKVCDAAGSGALLRSFLIEAAGRASGLGAPEVARFGDAALHLAAAVLERHFTDADEAGPQTEQHELLTRIRGFIDRNLGEPDLSPSLVASAHHISIRYLQRLFKTEGSTPSDWIRQRRLENSRRELCDAKLRSASIREIGLRNGFAQPSDFSRVFRANYGIPPGKFRDDWFRRDAVG	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	205.65	gnl|BL_ORD_ID|1537|hsp_num:0	1665			48	354	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001076.1|Liposidomycin_8 # 7573 # 8094 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGGGA;rbs_spacer=8bp;gc_cont=0.626	BGC0001076.1|Liposidomycin_8 	7573	8094	+	Loose	450	25.7942	ermZ	33.85	3004605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACAGTACTGACGTCCAGGACCGTGCTCGACATCGACCCGGTCAGGCTCCGCGAATCCGTGGCAAGCCTGTTGGAAAAGCATCCGTTGGTATTCGAGGGCACACGGCAACTCGCCCTCCAGCACCGGTCGGCGGCGACGGACCCGTGGTACGAGGGCTGCCAGCGGCAGTCGTTGATTTCCTCGGACTCCGACTTCACCGAGGTGCATGCCGAACTCCGGGATACCTACCTGGGCGAGGTGTTCGACCGGCTTCCGTTCAAGCCCATCCGCACGAGGATCATGGCACTGGACCCGAAGCACTGCTATTCGGTGCACCGGGACCTGACGCCGCGGTATCACCTCGCCGTCACCACGAGCGAGCACGCGAGGTTCGTTTTCATCGAGCCCGACAAAGTGGTGAACGTCCCGGCCGACGGAAACCTGTACTACGTCGACACGCGGCATCTGCACAGCGCATTCAATGGCGGGGACGAGATGCGGATTCACGTCGTCTTCGGGACCGACGACGAGCAGAGTTGA	MTVLTSRTVLDIDPVRLRESVASLLEKHPLVFEGTRQLALQHRSAATDPWYEGCQRQSLISSDSDFTEVHAELRDTYLGEVFDRLPFKPIRTRIMALDPKHCYSVHRDLTPRYHLAVTTSEHARFVFIEPDKVVNVPADGNLYYVDTRHLHSAFNGGDEMRIHVVFGTDDEQS	MTLKSPLPPQSVSAPADSRSTARREWGQNFFRTAAAACRFSAQLDGSDTIPPDSPNDLMTVEIGAGSGRVTKVLASPGTPLLAVEIDPRWARRLAAESLPDVTVVNEDFLTLQLPGQPVRLIGNLPFVTGTRMLRRCLDMGPARMRQGVFLLQREYVGKRTGAWGGNLFNAQWEPWYSFDRGLAFSRQDFTPVPRADTQTLMVAPHRRPSVPWREKAAYQRFVQRVFDTGQMTVGDAARKVLRRGHAQFVRGAGVRPADRVKDLTVPEWTALFRAYGRTADR	61.35	gnl|BL_ORD_ID|225|hsp_num:0	3303			402	579	spiramycin
BGC0001076.1|Liposidomycin_9 # 8123 # 8755 # 1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=GGGG;rbs_spacer=10bp;gc_cont=0.671	BGC0001076.1|Liposidomycin_9 	8123	8755	+	Loose	500	29.261	LlmA 23S ribosomal RNA methyltransferase	29.73	3003982	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target alteration	Llm 23S ribosomal RNA methyltransferase	TTGGTGGCGCATTGGGATCACCGTGCCGAGAACTATGACGAAACACCGGGTAATTCGCTGACGCCGGAACAGGCGGAGGCGTGGAAGTCGATGCTGGCGGATGTCTATCCCACGCGTTCGGGAAAACTCCTCGACATCGGCTGCGGGACGGGCACCTACTCGCTGCTGTTCGCGGAGCTGGGATTCGAGGTCCACGGCGTGGACACCTCGGAGGGGATGATCGCGCGAGCGCGGGAGAAGGCACTTTCCCGCAGCGGCCCTGGCGGCCCTCCCGCCGTCATGTTCTCGGTGCTCGACGCGCAGCACATCAGCGGCCGATACGACGCCGTCTTCTCCAGGAACATGCTGTGGACCGTGGCCGACCCCGGCCGGCTGACCGCAGTGGTGGGGGAGCACACGACCAAGTCCGCGGTGTGGGTCGCCGTCGAGACGATGTGGGACGGCCGCCCGAACGGCGACTTCCGGGACACGGGCGAGCACCTCCCCGGTTTCGGCGGCTGGCATCCCAACGTGCTCCGCGAGGTGTTCGCCCGGCACGGATTCACGCGCACCACGTGGTCGAGCATCTCCAACCGGTCGGAGCTGGCCACCGCGGACAAGGACATCCACGTGCTGTTCCGGGTGAGCCGATGA	MVAHWDHRAENYDETPGNSLTPEQAEAWKSMLADVYPTRSGKLLDIGCGTGTYSLLFAELGFEVHGVDTSEGMIARAREKALSRSGPGGPPAVMFSVLDAQHISGRYDAVFSRNMLWTVADPGRLTAVVGEHTTKSAVWVAVETMWDGRPNGDFRDTGEHLPGFGGWHPNVLREVFARHGFTRTTWSSISNRSELATADKDIHVLFRVSR	MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSGGGQWDMKKQLPDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGATVAAASAGAQVVHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGRGPSGETWKLEQSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPITRSGMNLPCGILGRWES	73.17	gnl|BL_ORD_ID|2227|hsp_num:0	2519			255	576	clindamycin
BGC0001076.1|Liposidomycin_10 # 8752 # 9309 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGTGA;rbs_spacer=4bp;gc_cont=0.686	BGC0001076.1|Liposidomycin_10 	8752	9309	+	Loose	375	45.4394	tmrB	26.63	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	ATGATTATCGTTGTCACGGGCCCCTGGGCGCTGCCGAGGATGGAGATCGCCCGATCGGCCGCCGATCGGCTCAGCGGCATCGAGGTGGTCGACGGAGAGCAACTGGGCTTCGCCCTGATGGAATTCCACACCGACCTGCCGGACAACTTCCAGGAGGACACGGTCTGGGAGGCACTGTTCACCACGCTGTGCGTGCACACCGCCCGGCGCTTCGGCGGTGACGTCCTGGCACCGATGAACATCCACTCGGGCGAGCGGCTGTCCCGCATACGGGCCGGCATCGCGAGCCACGGAGAAGCCGTCCACGTCGTGGGCCTGCGCTCGACCCGGGAGCACTGCGAGCAGCTGGCCGAGGCCTTCTCGTTCTTCGCGCGGGAGTCGGCGGACTACCACCGCGTACGGAACTGGCAGCTGGCACGGCTGGCCGAGTATCTGGAGTTCGTCAAGGACCCGCTGGCGCCGGTCGACCACTGGATCGACCTGACACCGGACGCGTCGCCGGCCTGGGTGGCCGAGTCGATCGCCCGGGCGATGACGCCACTGGTCGCGGGGCGCTGA	MIIVVTGPWALPRMEIARSAADRLSGIEVVDGEQLGFALMEFHTDLPDNFQEDTVWEALFTTLCVHTARRFGGDVLAPMNIHSGERLSRIRAGIASHGEAVHVVGLRSTREHCEQLAEAFSFFARESADYHRVRNWQLARLAEYLEFVKDPLAPVDHWIDLTPDASPAWVAESIARAMTPLVAGR	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	93.91	gnl|BL_ORD_ID|1654|hsp_num:0	1794			0	516	tunicamycin
BGC0001076.1|Liposidomycin_11 # 9313 # 10644 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=9bp;gc_cont=0.688	BGC0001076.1|Liposidomycin_11 	9313	10644	+	Loose	500	26.1794	OXA-60	44.83	3001808	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCCATGACGACCTGCCCGGAGGAAGCCCTGACCCGGGCACGCGACGCCGAGTGCGTGGTCGCGTACCGGCGTCTGCGGCAGGGAGTGTCCACATCGCACCAGATCGGATACGGCCGCAACATGTACCCCGCCGCACCCGAGTTGGTGGCGAGGATCCGTGCACTGATCACGGTGTTGTTCGAACAGCAGCGCATGACCGACTACTCCACCGAGTTCGACGGCTCCGACCGGCAACTGATCAGCGCGCTGGCCGCCAAGTGGCTGGGCCGCCCGGACATCGAGCCCGGCGACGTGTTCGTCATGGCCGGGTCGACCGAGGCGATCAGCGTCGTCACCCGGTATCTCGCCGGACGCGGGTACGAGTATGTGCTGCCACTGCCCTGCTACTACGCCTTCGAGCAGTCCGCCCGCCGATGGGGTATACCGGTCGCCGCCCACTACAACACCGACGGCCGGCTGCACGGCACCCGGTCGCACGCACCGAAGGCCCTGGTCGACATCGTGCCCAACGGGGTGACCGGCAGGCGTTTCCGATTGCCCGACGGTGTCGACGACGACTTCCACATCCTCGACTCTGTGTTCCAGGTGTCCGCGGCGGACGCCACCGGGAGCGCCGTGGACGACCGGCATCTGCGCGAGGCCGTCCAGGACGTCGATCTCGACAGGGGCTGCGTGATGCTGACCGCCAGCAAGGACCTGTCGGTCCCCGGACTGCGCGCGGGCCTGCTGATCACCAGGGAACCCGACCTGAGGCGGCATCTGGAGGCGGACCGGTTCGAGCGCTGCTACTCGCTGAATCCGCTGTCCACCAGCGTCGTGGCCCTGTACGTCGCGCTGATGTGCGCGCGGGCGTTGCGGGCGCAGGGCACCGCGGAACCGGGGCCCTCGCTGCTTCCTCCCGGGGTCCCGTTGAGCAGGCAGGCCGCCGACGATCCCCTCGCCCGGCTGCTGTGGCACTCACCGGTCGTCGACACCCTCGACCGGTACCTGCTCGGCATGGCGCGGCACTACGCGGCCGTCCTGGAGATCTACCGCAAGCGGCTCGTGCCGCTTGGCATCGCACTCGACTCCCGATACCCCGAGACCGGCTACTCCTTGTTCCTGCCGCTGCCGGTCCGGGTCGACGGGCCTGAGGGCGCGCTCGCCTGGTGCAACCGGGTCGGCCGGGAGGCCGGGCTCAAGCTCAATCCGGCGTCGATCTTCGGAGGCAGCGACGAGCCGTGGACTGCCCTGTACGACTGCACCCGCCCATGGGTGCGGTTCAACTGTTCAGTTGCGGAGCCGGATGCCGTCGGCACCGTGAACATCCTTGAAACGGCGTTGAGGTGA	MPMTTCPEEALTRARDAECVVAYRRLRQGVSTSHQIGYGRNMYPAAPELVARIRALITVLFEQQRMTDYSTEFDGSDRQLISALAAKWLGRPDIEPGDVFVMAGSTEAISVVTRYLAGRGYEYVLPLPCYYAFEQSARRWGIPVAAHYNTDGRLHGTRSHAPKALVDIVPNGVTGRRFRLPDGVDDDFHILDSVFQVSAADATGSAVDDRHLREAVQDVDLDRGCVMLTASKDLSVPGLRAGLLITREPDLRRHLEADRFERCYSLNPLSTSVVALYVALMCARALRAQGTAEPGPSLLPPGVPLSRQAADDPLARLLWHSPVVDTLDRYLLGMARHYAAVLEIYRKRLVPLGIALDSRYPETGYSLFLPLPVRVDGPEGALAWCNRVGREAGLKLNPASIFGGSDEPWTALYDCTRPWVRFNCSVAEPDAVGTVNILETALR	MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYVVDPARAARSIHPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEVARRVGFERMQAYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLLIEQQGDAALYAKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPAP	163.47	gnl|BL_ORD_ID|38|hsp_num:0	47			408	495	cloxacillin; oxacillin; cefalotin
BGC0001076.1|Liposidomycin_12 # 10649 # 11923 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGTGA;rbs_spacer=4bp;gc_cont=0.691	BGC0001076.1|Liposidomycin_12 	10649	11923	+	Loose	500	28.8758	AXC-3	34.69	3006899	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	AXC beta-lactamase	GTGACCGTGGGGGCTGATGGAAAGACAGCGGCGGACGTCGACCCGTTGATGCTGGGCAGGGCGATCGTCGATGCCGACCGGCGGGCCGCGCACGCCCTCAACCTCGTACCGAGCGAGAACCGGATCTCGCCCCTGGCCGCGCTGCCACTGGGGTCCGACTTCTACAACCGGTACTTCTTCAACACCGCCGGCGACCCGCTGTTCTGGGAGTTCCGCGGCGGGGAGGACATCGCGCACATCGAGGCGCTCGGCGCCCAGGCGCTCCGGCGGATGGCCTCGGCGCAGTACTGCAACGTACGCCCGATATCGGGGATGAGCGCGATGATCCTCACCGTCGCGGCCCTGTCGGCGCCGGGCAGGACCGTGGTGAGCATCGACCAGAACTCCGGCGGCCACTACGCCACCCCGGCACTGCTCGGCAGGATGGGCCGGCACTCCCGTCTGCTCGGCTGCAAGGACGGCCAGGTCGACGAGTCGGAACTGGCCGACGTACTCGCACCCGGCGACGTGGACCTCGTGTACGTGGACGTGCAGAACTGCGTCAGGGTGCCGGACTTCGGGCTGATGGCGGACGTGGTGAATCAGGTGAGCCCGGCCACGCGGCTGTACGTCGACGCCAGCCACTACCTCGGCCTCGTCCTCGGTGGTCTCGTCGAGAACCCTCTGGCGTGCGGGGCCGACGCCTTCGGCGGATCGACCCACAAATCGTTCCCCGGCCCGCACAAGGGCGTGATCTTCACCAACGCCGAGGACGTCGACGAGAGCCTGCGATCCGCCCAGTTCGACATGGTCAGCAGCCACCACTTCGCGGAGACCCTGGCGCTGTCCCTGTCCGCGCTGGAGGTCGAGCCCCGCATCGGGGACTACGCCTGGGCGACCACTGACAACGCGCGACGACTCGCCTGCGCACTGGCCGACGCGGGTTTCCGGGTCTACGGCGACAGCCGCAGCGGCTACACCGACACACATCAGGTATGGGTGGAACTGGACGGCACGGCAGACGCGTACGCCCTGTCGAACCGCCTTGCCGAGGCGGGCATCCGGGTCAATCTGCAGTCGTCGATGCCGGGGATGTCCGGCGTGCACCTGCGCCTCGGTTCGAACGAGGTCACCTTCGAGGGGGCCGGCCCGCAGGCGATCGAGCAACTCGCCGGCGCCCTGGCCACGGCGAGAGAGCGGGCGCTCGAACCGCGGACGGTGAGCGAGATCCGCGGGCGGTTCGGTGCGCCCTTCTACACCGATCCCGAGAAGCTGAAGTTGGAGGCCGGGTTGTGA	MTVGADGKTAADVDPLMLGRAIVDADRRAAHALNLVPSENRISPLAALPLGSDFYNRYFFNTAGDPLFWEFRGGEDIAHIEALGAQALRRMASAQYCNVRPISGMSAMILTVAALSAPGRTVVSIDQNSGGHYATPALLGRMGRHSRLLGCKDGQVDESELADVLAPGDVDLVYVDVQNCVRVPDFGLMADVVNQVSPATRLYVDASHYLGLVLGGLVENPLACGADAFGGSTHKSFPGPHKGVIFTNAEDVDESLRSAQFDMVSSHHFAETLALSLSALEVEPRIGDYAWATTDNARRLACALADAGFRVYGDSRSGYTDTHQVWVELDGTADAYALSNRLAEAGIRVNLQSSMPGMSGVHLRLGSNEVTFEGAGPQAIEQLAGALATARERALEPRTVSEIRGRFGAPFYTDPEKLKLEAGL	MLTRRTFIASAVLAGGMPALARARTDKKTRWTRDSLATFQQALAKLEAASRGRLGVALLDVGSGQAAGYRADERFLMLSSFKTLSAAYVLARADRGEDQLSRRIPITDADVQEYSPVTRLHVGPRGMTLAELCEATITTSDNAAVNLMHKSYGGPQALTRYLRGLGDTVTRHDRYEPELNRPHPSEPQDTTTPRAMARTLDTLLFGDALKPQSRQQLQSWLLANTTGGKRLRAGMPADWRIGEKTGTYSKVGCNDAGFAQPPGAAPIIIAAYLETTAVPMEERDRCIAEVGRLVAALG	142.28	gnl|BL_ORD_ID|3296|hsp_num:0	4365			330	468	
BGC0001076.1|Liposidomycin_13 # 12006 # 12836 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGG;rbs_spacer=8bp;gc_cont=0.693	BGC0001076.1|Liposidomycin_13 	12006	12836	+	Loose	300	25.0238	tet(36)	41.38	3000197	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGCAGCTGATGAAGTCGAGTTACACGGAGCTGACCGCACCCGGCCGCGGATATGTGACCGATCTGCTGAAGCCCGACGAGACGCTGGACATGCTGGAGACCTACGGATTCGCGGTGACGCGGAGCCCGTCGGCCACCGTGTCGGCGGAGGACGCCCACCGCGAGATGGCCGCGATACGCGCCGACCTGGGCCTGGGGGACCCCTACGTCCCGTTGCTGTACCGCGACCGGGACGCGCCGATCGTCACCGAGGTGACGAGGAAGGCGGACTCGGACCACCCGGTTTTCCACACCGGTGCCGCCCAGGGTTGGCACACCGACGGGCTCCTGGAGGCCATCGGGACCATCAAGACGACCCTGTTGTACTGCGTGCGTCCGGCACGCGGGGGCGGCCGTACGTTCCTGCTCAACGCGGGACGGGTGTTCGACGAGCTGCGGGCGGAGGATTCCGAGGCGGCCGGGATCCTGCTGCGGGACACGATTCTCGGCAGGCGGTCGACGATCCCCGGCGTGGACCGCGAGGCCGTCGGGCCCGTGTTCGCCGAGCTGGGGGACGGCCACTACGCCACCCGCTACGGCCAAGGGCAGGTCGAGCACTGGTACCCGAAGGACGCGGCCGAACAGAAGGTGCTCGATCGTGCGCTGGCCTACTTCACAGCGCGACGTGACGACCCGGACGTCCGGATCGACCTGCTCCTCCGGGCCGGCCAGTGCCTGATCTTCCGCAACGACGTGCTGGCCCACGGCAGGGAGCACTTCACCGACGACTCACGGCACCCGCGTCTGCTCCTGCGCAGCCTGCACACCGACGCACCGAAGCGCACGGCATGA	MQLMKSSYTELTAPGRGYVTDLLKPDETLDMLETYGFAVTRSPSATVSAEDAHREMAAIRADLGLGDPYVPLLYRDRDAPIVTEVTRKADSDHPVFHTGAAQGWHTDGLLEAIGTIKTTLLYCVRPARGGGRTFLLNAGRVFDELRAEDSEAAGILLRDTILGRRSTIPGVDREAVGPVFAELGDGHYATRYGQGQVEHWYPKDAAEQKVLDRALAYFTARRDDPDVRIDLLLRAGQCLIFRNDVLAHGREHFTDDSRHPRLLLRSLHTDAPKRTA	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	43.12	gnl|BL_ORD_ID|1675|hsp_num:0	1708			645	732	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001076.1|Liposidomycin_15 # 13519 # 14667 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.701	BGC0001076.1|Liposidomycin_15 	13519	14667	+	Loose	375	30.0314	ALI-1	50.0	3006894	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALI beta-lactamase	ATGCCCGGAGTTCTGATGGACTGCACCGGTCATCGCGTCGACTGGGCGTCGCTCGGCGGAATCGGGCTGCGCGCCCGGGAACTCGCCGCGGAGATCGCGCGGATCGCCGACGTCGCGATCTTCTCGCCGGAATCGCGGCCCGAGACGCTCGACGCAGGTGTCCGGCTGGTGACCCGACGGTCCGACTGGGCGGCCGAACTACGGCGCAGCGACCTGGTGTACAGCTTCGACTCGCCGTCCCCCGAGCGACTGTCGGACCTGGTCCGCAGTGGCAAGCCGGTGATCGTGGAGAACGCCCCGCCCCTCGAACACGCCCTGTACCCGTCCCTGGCCCGCAGCGCGGATCGCGAGGAGGTCTACCGGCACACCGTCGAGGCGTACCGGGAACAATTGGCGAGCGGAACGTTCTTCACCTGCCGGTCGGCCGTGGAGCGGGCGACGCTGGTGGCGAACCTCTGTGTCACCGGCCGCGTCACGGTCGAGGCGATGCAGGCATCGGGAGCGCTCGACTCGACGGTCTGCACGATCCCGATCGGATTCTCGGAGACCGCCGCCGCGGCGGCACGCCACGAACTCACCCGGACGAAGGCCGACCAGACCTTCCGAGTGGCCTGGTCGGGCGGCCTGTGGACCTACCTCGACCCGGTGTTCGCCCTGGACGCCGTACGGATCGCCCGGAGCCGCGGAGTGCCCGCGGAGCTCGAGTTCCTGTACGGGCGCGGCAACGCCGACAACGCGTCAGTCATGTCCGAACTCCTCGACGCCATCGAGAACCGGGGCTGCGGCGACTTTGTGACCCTGCGCCGGACTCCGCTCAGCCACGAGGAGTACTTCCGGGTGCTGGCCAGGACCTCCGCACTGATCTGCGTCGGCCGGCGCGGCGTCGAGAACGACACCTGCGTGCGGCTGCGGGCCAGGGACTCGCGGCTGTTCGGCCTGCCCACCGTGCTCGACCGGCACGGCCCGACGTTCGACGAGCTGACCAGGGACGGACTGGCCCACGGCGCGGACGACCCGGAGGAAGCCGCCGACGCCCTGGAGGCGATCCATCAAAGCCGCGGGGACCGCGTTCCCCTCGACTCCTATTCGTACCGCCGTACCGCGCGCGACCTGTGCACATGGATCGAGAAGGGGAGCTGGAGACGATGA	MPGVLMDCTGHRVDWASLGGIGLRARELAAEIARIADVAIFSPESRPETLDAGVRLVTRRSDWAAELRRSDLVYSFDSPSPERLSDLVRSGKPVIVENAPPLEHALYPSLARSADREEVYRHTVEAYREQLASGTFFTCRSAVERATLVANLCVTGRVTVEAMQASGALDSTVCTIPIGFSETAAAAARHELTRTKADQTFRVAWSGGLWTYLDPVFALDAVRIARSRGVPAELEFLYGRGNADNASVMSELLDAIENRGCGDFVTLRRTPLSHEEYFRVLARTSALICVGRRGVENDTCVRLRARDSRLFGLPTVLDRHGPTFDELTRDGLAHGADDPEEAADALEAIHQSRGDRVPLDSYSYRRTARDLCTWIEKGSWRR	MFKLTLALLSSVIGFNAAAEPVVKPLQFEEITNNVFLVKSYREFKNLQSPKKPILVDANSLVYVDGKDAYLIDTPWNASNMPQLMTWIENRGLTLKKTVFSHFHEDQTGGLEYLQEHHFETYASALTNKFLKGDNKKATNHQFSGDNFVLLENKIEVFYPGGGHTKDNAVVWLPKEKVLLGGCLMRANEVNTIGWTGDADMKAWAGSAQKVLTKYPQANFVVPGHGNVGEGTSIISHTVDITGKI	155.92	gnl|BL_ORD_ID|3291|hsp_num:0	4360			228	306	
BGC0001076.1|Liposidomycin_16 # 14664 # 15938 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=10bp;gc_cont=0.709	BGC0001076.1|Liposidomycin_16 	14664	15938	+	Loose	350	27.7202	AAC(2')-Ib	33.33	3002524	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGAATTCCGGAGACGAGACAGCTTCCGCTCTGGGGCGCCCCTGGAGGGCTCCTCACGACCACTCCGGCCCGACGTTCGTCGCCGGCCGGGGCGCGTGGCTGGTCGACCGCGACGGACACCGGGTGATCGACGCGACATCGGGTGCCCTCAACGTCTTCTGCGGCCACGGGGTCGAGCAGGTCGTCGACGCCTACGTGTCGCAACTGCGGGCGCTGGCCCACGTCGACATGTCCCAGGGGCTCGCCGAGCCCGCACACCTGCTCGCGGACCGGCTGCGGGACCTCCCGGGGCACGGCGGCGACCGCTTCTTCTTCGCCAACAGCGGCTCGGAGGCGATCGAACTCGCCGTCAGGATCTCCTCGCTGTACTGGGCCGCGGTCGACAGTACGCGCACTGACATCATCACCTTCGAGCGCGGCTACCACGGTTCGACCGCGCTGTGCCAGTCGCTGTCCGGTCTGCCGCAGACCAGCACCATCGAGGATCGGTGCGGGGCAACTGTCCGCCATCTGACGTTCGGTGAGCTGGCCGGCGCCGAACTGCGCTGGCCCCAGGCACGTGAGCACATCACCGCGCAACTGCGGTCCCTCCTGGCCGACCGGGCCGTGGGCACGGTGCTCGTCGAGCCGTTCCTGAACGTTGGCGGCGGCATTCGGCTGCCCGAGGGACTCCTCGGCGACATCCGACGCATCTGCGACGAGTACGGGGCGCTGCTGGTGCTGGACGAGGTGTTCACGGGCCTCGGCAGGACCGGTGCGTGGTTCGCGCACGAGCACGAGGGAGTACGCCCGGACCTGATGGCCTTCAGCAAGGGCCTCACCAACGGCGTGTGCGCGCTGTCCGCGGTCGCGGCTGACGAAGGGATGCTCGAGCGCCTTCCCTCCGGGAGCATCGTGTCGTACGGCCACACCATGTCGGCCTCCGCCGCCGCCTGCGCGGCGGCGAGCGCGACGCTGGAGCACATGCGCGAGAGCGGGGCCGTCAGCGCGGCCCGCGAGATCGGCACCAGGTTGCTCGGCGCGCTCTCCCGGGAACTGCGAGGCGCCGACGGGGTGGTCGACGTCCGCGGACATGGACTGGCGCTGAGCGTCGAACTCGACGGCACCGACAGCGCCGAGAACGTCCAGCGGGTGGCGTACGACCTCGGAGCGTACACGCGGCAGCAGGGCAGCACCGTCATGCTCGCGCCGCCCGCCTGTCTGAGCGGCGAGGAAGAGGACCGGCTCGCCGACCACCTGGTCACCGCGGTCCGCAAAGTGGTCGCCGCACGGTGA	MNSGDETASALGRPWRAPHDHSGPTFVAGRGAWLVDRDGHRVIDATSGALNVFCGHGVEQVVDAYVSQLRALAHVDMSQGLAEPAHLLADRLRDLPGHGGDRFFFANSGSEAIELAVRISSLYWAAVDSTRTDIITFERGYHGSTALCQSLSGLPQTSTIEDRCGATVRHLTFGELAGAELRWPQAREHITAQLRSLLADRAVGTVLVEPFLNVGGGIRLPEGLLGDIRRICDEYGALLVLDEVFTGLGRTGAWFAHEHEGVRPDLMAFSKGLTNGVCALSAVAADEGMLERLPSGSIVSYGHTMSASAAACAAASATLEHMRESGAVSAAREIGTRLLGALSRELRGADGVVDVRGHGLALSVELDGTDSAENVQRVAYDLGAYTRQQGSTVMLAPPACLSGEEEDRLADHLVTAVRKVVAAR	MPFQDVSAPVRGGILHTARLVHTSDLDQETREGARRMVIEAFEGDFSDADWEHALGGMHAFICHHGALIAHAAVVQRRLLYRDTALRCGYVEAVAVREDWRGQGLATAVMDAVEQVLRGAYQLGALSASDTARGMYLSRGWLPWQGPTSVLQPAGVTRTPEDDEGLFVLPVGLPAGMELDTTAEITCDWRDGDVW	217.44	gnl|BL_ORD_ID|687|hsp_num:0	746			294	489	dibekacin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; gentamicin
BGC0001076.1|Liposidomycin_17 # 15949 # 17322 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.704	BGC0001076.1|Liposidomycin_17 	15949	17322	+	Loose	760	26.1794	macA	31.48	3000533	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAATGACGACGCGATCGGCGTTGACGACGTCCTGGAGCACATCGAACGGCTCCGCCACGGCGAGACGCTCACCATGAAGTGGGCGTCGGCCGTTCTCGACCTCCACCGAGCAGACAGGCTCGCCGACTACCAGCTCTCCTCATGGCTCGCGACCATCGCCGCGAGAGGGTTGCGATTCACCGAGACAGTGGCCCTGACAAGGGCATATCTCGGTCCCGGCGAGCGGCGGGACGGGGTACGCCGCGAGGGGCGAACCGTCGTGGACAAGCACAGCACGGGTGGCGTCGGCGACAAGACGACACTGGTGGTCGTGCCGCTGGTGACCGCGCTCGGCGTCCGGGTGTGCAAACTGAGCGGACGCGGGCTCGGTATCGCCGGGGGCACGATCGACAAGCTGGAGAGCGTACCCGGGCTCAAACTCGACTTCACCGAGGCGGAGTTGGCCACCCGGCTCGCCACGAACGACGTCGTCATCGGGTCCCTGTCCGGTGACCTCGTCCCTGGTGACACGGCGACCTACGGCCTTCGGTCGGTGAGCGGCTGTGTCCGGTCGGCGCCGCTGATCGCCGCGAGCATCGTCAGCAAGAAGGTGGCGGTCAACGCCGACGCGGTCGTCTTCGACGTCAGGTACGGCGCCGGGGCGCTGCTTCCCGACCATGGGTCGGCGCGCCGGCTGGCGGGGCTGCTGGTCCGGCTCGGGGGCGCGTTCGGGCTGCGCTGCCGGGCGGTGCTCAACGACGGCTCCGTCCCGTTGGGCACGGCCGTCGGCAACGCCGCGGAGGTCGACGAGGCCATCAGGTTCCTGCGCGGGAACGGTGACCGCAGGCTGATGGCGGAGTGCGAGGCCATCGCTGTGCAGATGGTCGGCTGCGCTGAACCGGACGAACCCGCGAGCAGGATCCGGGAACGGCTCCGGTCGGCGATCGAGTCCGGGGCCGCCCTGTCGGTCTTCGTCCGGATGCTGGAGGCACAGGGCGGCGACACCGGTCCAGTGCTTGCCGCAGAGGGCTACTGCAGACCCCAGGTGCGCACGGCGGTGCGCGCACGGCACACCGGCTGGGTCACCGACATCTCGTCCCTGGACATCGGCCGGGCCGCGCTGAAGCTGGGCGCGGGCAAGGTGTTCGCCCACGACGTCATCGACCCCCACGCGGGCATTCGGCTCGCCAGGGGACTCGGGGACCAGGTGGCCGAGGGGGACGTCATCGCCGAGGTGTTCCACCGCGCCGGACTGGACAGCGGTGAGGCGGTGGAGCTGGTGTCCCGCGCCGTCTCCGTCGGACGGCGGGAGGACTGCCGGCAGCCGGGCGATCCGGAGCCCGTGACCGAAGCGGATGTCCGCACAGACGAAACGGGGATGGTCCATGTCTAG	MNDDAIGVDDVLEHIERLRHGETLTMKWASAVLDLHRADRLADYQLSSWLATIAARGLRFTETVALTRAYLGPGERRDGVRREGRTVVDKHSTGGVGDKTTLVVVPLVTALGVRVCKLSGRGLGIAGGTIDKLESVPGLKLDFTEAELATRLATNDVVIGSLSGDLVPGDTATYGLRSVSGCVRSAPLIAASIVSKKVAVNADAVVFDVRYGAGALLPDHGSARRLAGLLVRLGGAFGLRCRAVLNDGSVPLGTAVGNAAEVDEAIRFLRGNGDRRLMAECEAIAVQMVGCAEPDEPASRIRERLRSAIESGAALSVFVRMLEAQGGDTGPVLAAEGYCRPQVRTAVRARHTGWVTDISSLDIGRAALKLGAGKVFAHDVIDPHAGIRLARGLGDQVAEGDVIAEVFHRAGLDSGEAVELVSRAVSVGRREDCRQPGDPEPVTEADVRTDETGMVHV	MAKMMKWSAVAAVAAAAVWGGWHYLKPEPQAAYITETVRRGGISRTVSATGEISPSNLVSVGAQASGQIKKLYVKLGQQVKKGDLIAEINSTTQTNTLNMEKSKLETYQAKLVSAQIALGSAEKKYKRQTALWKDDATSKEDLESAQDALAAAKANVAELKALIRQSKISINTAESDLGYTRITATMDGTVVAIPVEEGQTVNAAQSTPTIVQLANLDMMLNKMQIAEGDITKVKAGQDISFTILSEPDTPIKAKLDSVDPGLTTMSSGGYNSSTDTASNAVYYYARSFVPNPDGKLATGMTTQNTVEIDGVKNVLLIPSLTVKNRGGKAFVRVLGADGKAAEREIRTGMRDSMNTEVKSGLKEGDKVVISEITAAEQQESGERALGGPPRR	116.58	gnl|BL_ORD_ID|1546|hsp_num:0	1680			210	369	erythromycin
BGC0001076.1|Liposidomycin_18 # 17315 # 18379 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGGGA;rbs_spacer=6bp;gc_cont=0.692	BGC0001076.1|Liposidomycin_18 	17315	18379	+	Loose	650	29.261	ALG6-1	42.11	3006893	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG6 beta-lactamases	ATGTCTAGCGGGATCACCGCACCCGCATCCGAAGAGGCTGCCCGGGAGTACCTGTCGGAGATGCTCCGATGGCATTTCGACAAGGAGACGGGGTCGCGGTTCTGGGTCGAGTACCGGGACACGCTGCCGTTCGACCCGGTCACCGACATCCACACCTTCGACGATCTGCGCCGCTTCCCCTCCCGGGTCAACGAACTGCGCGAGGTCAGGGTCGAGGACCTGGTCCCCCGAGGGGCGACGGAGGAACCCCCGCCCTACGTGGTGGAGTCCGGCGGCACGACCGGCAGGCCCAAGAGGGCCGTCCTGTCCCGCACCCGTATCGAGCAGCTGGTCGACATGTACTGCGCCTACGTGCCGGAGGCCGAGGGACACACCATGCTGTCGCTGTTCCCGACCGGCCCCCACCTCGCGGGGAACTGGCAGCGACGGTGGGCACAGCGGCTGCGTGTGCTCTACCTCCAGGTGGACATCGACCCGCGCTGGGTGAAGTGCGGGATCGGCGCGGAACTCCAGGAGCGCTACGCGGACCACGTCCTGGCCCAGGCCCGGGACGCACTCACCACGCAGCATGTCGGCCACCTGCTGGTGACCCCTCCGTTGCTGCGCCGGATAGCGCGGTCCGAGAAGCTGGCGGAACTGGTGCGCGCCACGGTGCGGGTCATCACCTGGGGCGGCGCGCGCATGACGCGAGAGGAGCTGTACGAGTACGCGCAGATGGTGTTCCCGGATACCGTCTTCGCCGCCACCTACGCGAGTTCGATCACCGGAACCCGGGCACTGCTCAGGCGCTCGACGGCATTCGACGACCTGCCCGTGTTCGACCCGGTGGGCCCCGAGCTCTTCGTCCGCGTCGTCGACCCGAGCACACGCGCGCCCGTGCCCTACGGAGCCCGGGGCCAGGTGCTGATGCACACGGTCACACGGGACATGTTCCTGCCGAACAACCTGGAGCGGGATCTGGCCGTGCGGGTGCCCCGGGGCGAGGAGTGGCGGGGCGACTCGATCGCGGACGTCGTCCCGCTGTCGGAGTTCGAGGGCAGCCGCGTGGTCGAGGGGATCTACTGA	MSSGITAPASEEAAREYLSEMLRWHFDKETGSRFWVEYRDTLPFDPVTDIHTFDDLRRFPSRVNELREVRVEDLVPRGATEEPPPYVVESGGTTGRPKRAVLSRTRIEQLVDMYCAYVPEAEGHTMLSLFPTGPHLAGNWQRRWAQRLRVLYLQVDIDPRWVKCGIGAELQERYADHVLAQARDALTTQHVGHLLVTPPLLRRIARSEKLAELVRATVRVITWGGARMTREELYEYAQMVFPDTVFAATYASSITGTRALLRRSTAFDDLPVFDPVGPELFVRVVDPSTRAPVPYGARGQVLMHTVTRDMFLPNNLERDLAVRVPRGEEWRGDSIADVVPLSEFEGSRVVEGIY	MSHGIPCAPSSRMETQMVSKMAMAAILLLAGPTAAAEVTPTTPIVCSMCEGWNRPQKPFKIYGNTWYVGTNDLSALLVTSPNGHVLLDGALPQSAPLIEANIQALGFKLKDVKLILNSHEHFDHAGGIPALQRASGATVAASIRGAKVLRAGTVGKDDPQFDPVKPFFLAKLEKVREVADGETLTAGDLRITAHYTPGHTPGGTSWTWTSCENGRCLNMVYADSLTPVSSEGFRFSGGNGAPDISSAFQATIDKVAALKCDVMVSNHPGFSQVMEKLAARTDANNTFIDPTGCRKYAAAASKRLANRLATEAKQKAAR	111.32	gnl|BL_ORD_ID|3290|hsp_num:0	4359			405	516	
BGC0001076.1|Liposidomycin_19 # 18379 # 19866 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGGGGA;rbs_spacer=7bp;gc_cont=0.712	BGC0001076.1|Liposidomycin_19 	18379	19866	+	Loose	750	25.7942	adeA	28.95	3000774	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCAGCGGCCGGGACCGACAGAAGGTCCCCGTAGTGCGAACCACCACTGCCGGCAAGGTCGGCGGGGCGCAGTACCGCTCGTCCGGCTTCGCCATGTGGCGGGGCATTCCGTACGGCGCGGCACCGGCCGACGGCGGCCGGTTCGCCGGCCCGGTGCGGCCGACGCCCTGGGACCGCGTACGCCCGGCGCTGCGCCACGGCAGCATGTCCTGGCAGCTCCCGCCCGTCTACGACAAGGCGTCCGATGTCATGCGGGAGTTCGACTTCGCGCACACCGCCGACCCGGAGCACGAGGACTGCCTGAACCTCAATGTGTACACACCCGATCCCGGGCGCGCGGGCCTTCCCGTACTCGTCTGGTTCCACCCCGGCATGCAGGTCGCGGGATCGGGAAACATGCCCGGCAGGCACCCCGAGGTGCTCAGCCGCAACCACGGCGTCGTAGTGGTGACGATGAACTTCCGCCTGGGGTGCTGGGGCCATCTCTTCCTCGGCGACCTGGAGGGCCTGGACGCGCCGGACGCCGCGAATCTCCGGCTGCGCGACCAACTCCTCGCCCTGACCTGGGTGAAGGAGAACATTGCGGCCTTCGGCGGCGACGACACCAACATCACCGTGTTCGGGGAGTCCGCAGGAGCGCGCAACATAGGGTCCGTCCTGGGGTTAGACGCCGCCGACGGGCTCTTCGAGCGGGCCGCGCTGTACAGCGGCGGGTGCGAGAACGTGATGCCGCGGGACGAAGCGACGGAGTTCGCCCGGGAGTTCCTCGACCGCGCCGGCCTCACCGACGCCCCCGAGCGGATCTTCTCCGTCCCGAACGTACACCTGAAGGTGGCCCACGAACGCCTGCTCAGGCGACACGAGATCGTGCACTACCGGGACGTCGTGGACGGTGTCCATCTGTCCCGCACACCGATCGAGGCCATCAGGGCGGGCACCGGCGGCAAGGTCGACCTCTTGGTGTCCAACACCGCTGACGAGGCCGGCCTGTGGGACCGCCTGATGCCGGGCGGGGCGCGCGTGGTGGCGCAGGGCGCGCGGACCGCGGCGACACCGAGGGAGCGGTACGGAACCGACCACGAGCGGTTCATCAACGAGGAGTTGTTCCTGCGCCCGTCGCGCGACCTGCTCCGCGCGAAGGCCACGTCGGGCGGCGGCCGCTGCTGGTATCAGGTGTACGACTACGTTCCCTCCGACCACGGCTTCGCCGATGCGGAGCGCGCGCTGCACGGCATGGACCTCGCCTCGCTGCTGCTCGACGTCTCCGCCCCCGGCGCCGCGTCGGAGGCGGATGTCGCGGTCGCCCGCACCGTCCAGTCGGCGCTCGTGGACTTCGCGAGCGGGAGGGTCCCCTCGGCAGGCGGCCTCACGTGGCCCGTGTACCGGACGGACACGGAGCAGTGCGTCCGCATCGGACGGCAGCCGAGCGTGGACACCGTGGTGTGGCCGCTGGACGACGAGACCGCGGCAGCGGGCCGTCCGTGA	MGSGRDRQKVPVVRTTTAGKVGGAQYRSSGFAMWRGIPYGAAPADGGRFAGPVRPTPWDRVRPALRHGSMSWQLPPVYDKASDVMREFDFAHTADPEHEDCLNLNVYTPDPGRAGLPVLVWFHPGMQVAGSGNMPGRHPEVLSRNHGVVVVTMNFRLGCWGHLFLGDLEGLDAPDAANLRLRDQLLALTWVKENIAAFGGDDTNITVFGESAGARNIGSVLGLDAADGLFERAALYSGGCENVMPRDEATEFAREFLDRAGLTDAPERIFSVPNVHLKVAHERLLRRHEIVHYRDVVDGVHLSRTPIEAIRAGTGGKVDLLVSNTADEAGLWDRLMPGGARVVAQGARTAATPRERYGTDHERFINEELFLRPSRDLLRAKATSGGGRCWYQVYDYVPSDHGFADAERALHGMDLASLLLDVSAPGAASEADVAVARTVQSALVDFASGRVPSAGGLTWPVYRTDTEQCVRIGRQPSVDTVVWPLDDETAAAGRP	MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRTAEIRPQVGGIIEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPSNAISKQEVSNAQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMATIQQIDKVYVDVKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTFRIEVNNTERKLLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGQQYEQFYIANKGLKVGDRVVVEGIERIKPNQKLALAAWKAPAVANHASSVETKTSIAEGAQP	125.00	gnl|BL_ORD_ID|1210|hsp_num:0	1313			1074	1188	tigecycline; tetracycline
BGC0001076.1|Liposidomycin_20 # 19917 # 23576 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.714	BGC0001076.1|Liposidomycin_20 	19917	23576	+	Loose	1100	258.07	tetB(60)	30.02	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGCGGTTGATCGCGTCGTGGGCCGCCGACCGGCGGCGGGCGGTCGGCGCCGTGGTGCTCGCGCTGGCCGGCGCCGGGATCGACCTCGCGACGCCACTGGTCATCAGGTCGGTGGTCGACGGCCTGTCCGCCGGACGGGCGGTCGGCATCGGCGCGCTCGTCATGCTCGCGGTCGCCGCCGTCCTCAGGTTCGTCGTCCAGTTCACGCAGCGTACGACCGCGAGCCGCCTGGCGACACGGGTACAGCACGACCTGCGCGTGACCCTGCTGGCCGCGGTGTGCCGCTACTCCGGTGAGCGGCAGGACGCGTTGCGGCGTGGCGAGGTCGTATCGAGGTCGATCACCGATTTGCAGGTGGTCCAGTCGCTGCTGGCGCTGGCCCCGCAGGCGGCCGCGGCGGTGCTGCACGTCGCCATCCAGATGGCGATCATGTTCTTCCTGTCGCCGGTGCTCGCCCTGGTCGCGCTCGGCACCATCCCGCTCGCCGGTGTTCTGGTGGTCCGCTCCCGCCGGCGGATCTACGCGGCCACCTGGCTCTCCCAACAGGCGGCCGCCGACCTGACCTCGTTCACCGGGGAGGCCATAGCCGGACTTCCCGTCACCAAGGTGTTCCGCCGGGAGGAGCTGACCGAGCGGCGTTACGGGGGCATGGCCCGAGAGCTGTTCGGGCAGCGTCAGCGGGTCGCCCGTCTGAATGCCGCCTTCAGCCCCGGCCTGACCGCCCTGCCGCAGTTCGCGCTCGTCGTGGTCATGGGAATCGGCGGGCTGATGACCCTGCGCGGCGAGATCAGCGTCGGCACATTCATCGTGTTCGCCACCTACCTGCTCACCATGACCGGACTTGTCCGGCTGCTGGCCGGAGTGGTCTCCGCCACCGCGCTCGCCAGGTCGTCCGCCGACCGGATCCACGCGGTCATCGACGGCGGCGACCAGGCTTCGGCTGCCGACGGCGACACGCCCCGGACCGCGCGCGGCGGTCGCCTCGGCGTACTGCTGTCCGACGTCGAACTGAGCCTGGGGCCACAGTCGAGGAACGTGCTGCGGGGTGTGAGCGTCGAAGTCGCTCCCGGCGAGTGTCTGGGCGTGGCGGGCAGGGCGGGCTCCGGGAAATCGGTCCTCGGACTGGTGCTTCAGGGGCAGTACCGGCCCAGCGCCGGGCGCGTCGAATTCACCGGCGGCACGGGCGGTTCGGGGACCGCACGGCTCGGCGAGGCGGACGTCGTCCTGGTGCCGGAGGAGCCGTTCCTGTTCTCCGGGACCATCAGGGACAACATCCTGCTCGGCCGGGAGTTCGACGGCGACAGCTATGCATCCGCCCTCACCGACGCGGCCGTCGACGCACTGCTCGAACGCATGCCGGACGACGACCGGACCCACGTCGGTGAGAGCGGCGCCCGGCTCTCGGGCGGCGAACGGCAACGGATCGCACTGGCCCGCGCCCTGTACGACGCTCCGGCTGTGCTGGTGCTCGACGACGCCACGTCAGCCCTGGACACCCTGACGGAGGCTCGGGTGTTCGACGCGCTGCGCAGACGACTCGGGCAGGGCTGCACCATGGTCGTGACCGGCAGGCGTCGCACGGTGCTCGCGCTCGCCGACCGGATCGCCGTCGTCGAGGGCGGCCGTGTCGTCGAGCAGGGTGCAGCCGGGCACCTCCTGCGGGACTCCGTACGCCTCAAGACCCTGATCGGGGAGGCGACTCACACACCGACGCTCGGCGCCGACGACGTCGCGAGCGAGGAGCCCGACCCACGCGGGACGCAGTCGCCCGGCGGTGCCCCCGGGCGGGCGGGACCCGGCGAGCAGGACCCGGCAGAGGCCCTCACCCGGTATGCCACCGCGCTGCCGCCGGTCGTGGACGAGCCCGCCGACGCCGATGTCGACAACGGTCGGCGCGACGGCCCGCTCGGCATCCGTGAGGCGTTGCGGCCCGTCCGCTCGGTAGCCGTCGCGGCGCTGGTGTGCATCGGGTTCGAGGTCGTAGCGGCCGTGGCACTGCCGACGGTGGCGCGGTCCGTCCTCGGGCGTTCGGCGGCCGGCGACGCCACAGCGGTCGGGCTGCTGTTCACCCTGGGGCTTGCGATCACCGCCGTCAGCTGGATCGCCGGATGGGGAACCGTCCGCGCGACCACGCGGGTGTGCGACCGTGTGCTGTTCGCCGTACGGCTGCGCCTCTTCCGCCATGTCCAGCGTCTACCGCTGAGTTACGTGGACCAGGTGCGCTCGGGGGGCCTGCTCACCCGGATGACGGCGGACGTCGACTCCCTGTCCGCGTTCCTGCAGACCGGTCTGCTGTCCCTGATCGTCAACCTGCTGCTGGTGCTCTGTGCCGCCGTGGTGGTGGTGTTGATGGTTCCCGGCTTCTGGCCCGTCCTGGCCGTGGCGGCGGCCGCAGTGCTGGTCGGAGCGGCTGCCTTCCAGCGGATCGTCTCCCGGTCGTACCCGAGGGCGAGGGAACTGCTCACCGCGGTCAACGCCGACCTGCACGAGAAGGTGCATGGGGTCCGTACGGCACAGATCTTTCGCTGCACCGGGCCGATCGTCGCCCAGTTCGCAAAGAAGTCGGCGGCCTACCGCGACGAGCGGCAGCGCGGGCAGCGTGCGGTGGCCTGGTTCTTCCCCTTGGTGGCGCTGACCATCGACACGGCGTTGATCTGCGTACTGCTGCCCGCGGCGGTGCACGGACTGCCCTGGGCGGCCGGTCACGGCAGCGCGACGACAGCCGCGCTCATCCTGTACCTGTCCATGCTGTACTACCCGATCCAGCAGATCGCCACCGTTTACGACAGCGCTCAGCAGGCGAGGGTGGGCCTCCGTCGCATCAACGGCCTGTTGTCGGAGCCGCCCGAGGAACTGCTCGGGGGCGCCCCGGTCCGGGCACCGAGCGGCGGGGGCGTCATCCGGTTCGACCGCGTCGGCTTCAAGTACCGCGACGACGCCCCCTACTCGCTCCTGGACGTCGTGCTGGACATCCGGCCGGGCATGTCGGTCGCCGTCGTCGGCCCGACGGGCGCGGGGAAGTCGACGATCATCAAGTTGCTGGCACGGTTCTACCAACCGCAGCAGGGGGCGATCCGCGTCGGCGGCGTGGACGCTGCCACGATTCCGCTGCGCGACTACCGGCGGCGGACGGCCATCGTGCCCCAGGAGGCGCATCTGTTCAGCGGCTCTGTCGCCGAGAACATCGGGTTCGGACGTCCGGAGGCGTCAGCGGCGGAGATCACGGACGCCGTCCGTGCGTTCGGCGCGTCGGAAATGATCGACTCCCTGCCGGGCGGACTGGACTACGGCGTAGGCCCGCGAGGCTCGGCGCTGTCCGCGGGACAGCGGCAGGTTGTCGCCCTGCTGAGGGCGATCGTGTCCGACCCGGACCTGCTGCTGTTGGACGAGGCGACCTGCGCGCTGGACCTGGAGTCGGAGCGAAGCATCGTCAACGCGCTGCGCGACGGCAACGGCGCACGCAAGACCGTGCTGGTCGCCCATCGGCTCGCCACCGCCGCGCAGGCCGATGTCATCGCCGTCGTCGAGCGCGGCCGGCTGCTGGAGACGGGCGGGCACGAGGCTCTCCTGAGGTCGGGCGGGCTGTACGCGGATCTGTGGGCGGCCTCCGACCAAGACGGAGCGACGAGCAATCGAGGAAGTGGAGGCACGGCATGA	MVRLIASWAADRRRAVGAVVLALAGAGIDLATPLVIRSVVDGLSAGRAVGIGALVMLAVAAVLRFVVQFTQRTTASRLATRVQHDLRVTLLAAVCRYSGERQDALRRGEVVSRSITDLQVVQSLLALAPQAAAAVLHVAIQMAIMFFLSPVLALVALGTIPLAGVLVVRSRRRIYAATWLSQQAAADLTSFTGEAIAGLPVTKVFRREELTERRYGGMARELFGQRQRVARLNAAFSPGLTALPQFALVVVMGIGGLMTLRGEISVGTFIVFATYLLTMTGLVRLLAGVVSATALARSSADRIHAVIDGGDQASAADGDTPRTARGGRLGVLLSDVELSLGPQSRNVLRGVSVEVAPGECLGVAGRAGSGKSVLGLVLQGQYRPSAGRVEFTGGTGGSGTARLGEADVVLVPEEPFLFSGTIRDNILLGREFDGDSYASALTDAAVDALLERMPDDDRTHVGESGARLSGGERQRIALARALYDAPAVLVLDDATSALDTLTEARVFDALRRRLGQGCTMVVTGRRRTVLALADRIAVVEGGRVVEQGAAGHLLRDSVRLKTLIGEATHTPTLGADDVASEEPDPRGTQSPGGAPGRAGPGEQDPAEALTRYATALPPVVDEPADADVDNGRRDGPLGIREALRPVRSVAVAALVCIGFEVVAAVALPTVARSVLGRSAAGDATAVGLLFTLGLAITAVSWIAGWGTVRATTRVCDRVLFAVRLRLFRHVQRLPLSYVDQVRSGGLLTRMTADVDSLSAFLQTGLLSLIVNLLLVLCAAVVVVLMVPGFWPVLAVAAAAVLVGAAAFQRIVSRSYPRARELLTAVNADLHEKVHGVRTAQIFRCTGPIVAQFAKKSAAYRDERQRGQRAVAWFFPLVALTIDTALICVLLPAAVHGLPWAAGHGSATTAALILYLSMLYYPIQQIATVYDSAQQARVGLRRINGLLSEPPEELLGGAPVRAPSGGGVIRFDRVGFKYRDDAPYSLLDVVLDIRPGMSVAVVGPTGAGKSTIIKLLARFYQPQQGAIRVGGVDAATIPLRDYRRRTAIVPQEAHLFSGSVAENIGFGRPEASAAEITDAVRAFGASEMIDSLPGGLDYGVGPRGSALSAGQRQVVALLRAIVSDPDLLLLDEATCALDLESERSIVNALRDGNGARKTVLVAHRLATAAQADVIAVVERGRLLETGGHEALLRSGGLYADLWAASDQDGATSNRGSGGTA	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	210.54	gnl|BL_ORD_ID|2307|hsp_num:0	2646			30	1725	tetracycline
BGC0001076.1|Liposidomycin_21 # 23573 # 24607 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.654	BGC0001076.1|Liposidomycin_21 	23573	24607	+	Loose	950	28.4906	fusH	40.0	3003026	protein homolog model	n/a	n/a	fusidane antibiotic	antibiotic inactivation	fusidic acid inactivation enzyme	ATGAAGTCGTTGGCATGCGGTGAGGAGTTCCGGTTCAACGGAGCTGTTTCGTTGCAGCAGGGTGAGAACTGGCTGGCCCCGTGGCGGGTGCCCTTCGACGAGGCCCGGTTGTACTTCCCGGAGGGAGGCATCGGACGAGCCGCCATGCCGTCCGGGGTGTCCATCGCCCTGATGACGAACGCGACGCGGATTGACGTGGACTACCTGTGTTCACGGTGCCCCGACAACATCATCGACCTCGCCGAGGACGTCGAACAGCTGGAATCCGTCGATGTGACGGTGGACGGGCACTACCTGGGGCGGCGTGGCCTGTCGGCCTCGAAGACCGAGGACACCCTGCGACTGGAACTCGAAAACGACGGCGGTGGTGAGCGGCTGGTCGAGCTCTGGCTGCCGCTCTACGCCCAGTTCCGGCTGATCGACCTGCGGGTCGAGGAGGGTGCGACGGCGTCCGCGCCGATCCCGAACCCGAAACGCTGGGTGCACTACGGCGGTTCCCTGTCACAGGGGATGGGGGCGAACTCCCCCTTGACCAACTACGTCCAGACGAGCCGCTGGCGCACCGACCTCGACCTGGTGTCGGTGGCCCGGGGCAAGGGCACCCACATGGAACCCGTGTTCGCGGATCTGATCGCCGGCCTGCGGCCGCGCTACGTGACCATGGCGGTCGGCGGAATGGTCTACCTCACCGGATCACTGAATCAGTACACGTATCTCACCAACATGCTGGGGTTCGTGAAACGCGTCATCGATGCCGTGCCCGACTGCGAAGTGGTCGTGATCGTGCCACCGATGAGTCCTCGCTACCGCGACTTGCGGGGACCGGGCGGGATGACCGCGTCGGAGATGGTCGAGATGCACTACTCCACCGTGGAGACAGTGATGAAGTGGGGCGACAAGCGGGTCGGTCACATCCCCCAGTGGTCGGACGTCGACGAGTCCGACTTCCTCGCCGACGGCATCCATCTGACGTCGAGCGCCCATCGCCGGTACGGGGAGTACCTGGCGCAGGGGATACGGGAGCGCCTGGGATAG	MKSLACGEEFRFNGAVSLQQGENWLAPWRVPFDEARLYFPEGGIGRAAMPSGVSIALMTNATRIDVDYLCSRCPDNIIDLAEDVEQLESVDVTVDGHYLGRRGLSASKTEDTLRLELENDGGGERLVELWLPLYAQFRLIDLRVEEGATASAPIPNPKRWVHYGGSLSQGMGANSPLTNYVQTSRWRTDLDLVSVARGKGTHMEPVFADLIAGLRPRYVTMAVGGMVYLTGSLNQYTYLTNMLGFVKRVIDAVPDCEVVVIVPPMSPRYRDLRGPGGMTASEMVEMHYSTVETVMKWGDKRVGHIPQWSDVDESDFLADGIHLTSSAHRRYGEYLAQGIRERLG	MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDTLRGCSAALVHQQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVTTVEPVRLAADAPVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPALRGTGGEVELAAVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRSNGDVVVHRNLGDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQGTHWSGGWGRFIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKADLLVRTKDGKVALRTNHGTYWDQGKFMITL	67.58	gnl|BL_ORD_ID|65|hsp_num:0	75			984	1119	fusidic acid
BGC0001076.1|Liposidomycin_22 # 24699 # 24887 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=GGGA;rbs_spacer=8bp;gc_cont=0.714	BGC0001076.1|Liposidomycin_22 	24699	24887	+	Loose	230	26.5646	ramA	32.56	3000823	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	GTGCAGGATGCGGAGCAGGTACAGGGCGACGAGCCGACCGAGCCGACCCCACCGGCAGAAGGGGCCGGGCCGGCGACGGCGACCGGGCCGGCCGCTGACAACGACCTCGACTGGTTCGAGGACGTGCCCGAGGAGAACGTCGGGGCCGTGCTGTCGCTGGACGAAATAGCCCCGTACGCGGGCATCTAG	MQDAEQVQGDEPTEPTPPAEGAGPATATGPAADNDLDWFEDVPEENVGAVLSLDEIAPYAGI	MINQEAEGESSMTISAQIIDTIVEWIDDNLHQPLRIEEIARHAGYSKWHLQRLFMQYKGESLGRYIRERKLLLAARDLRESDARVYDICLRYGFDSQQTFTRIFTRTFNQPPGAYRKENHSRAH	50.00	gnl|BL_ORD_ID|1537|hsp_num:0	1665			15	132	tigecycline; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0001076.1|Liposidomycin_24 # 26778 # 27806 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0001076.1|Liposidomycin_24 	26778	27806	+	Loose	660	57.7658	MexS	26.71	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGGCCGTGTTCGCGTCCGCTCCCGATCCGGACGACCCGCTGTCCGCCGTCGTCGTCGGGCATCGCCCCGAACCCGAGGTGCCGAGGGGCTGGGTGCTGGTACGGGTCCGTGCCGCGTCCTTGAACCACAAGGACCTGTGGACCCTGCGCGGTGTCGGGATCAACCGCGACCAGTACCCACGCATCCTCGGCTGCGAGGCAGCCGGAGAGACGCCGGACGGCAGGCGAGTGGTGCTCTACCCGCTGCTGGATGCCCCACCGGGTACGAGCGACGAGACATTGGTGATGCCCGCGGCCCAGCTCGTCGGTGCCAGGCCCGGCACGCTCGCCGAGTACTTCGTCGCACCCCCCGAGAGCCTGCTGCCCGTCCCCGACCATCTGACCTGGGAAGAGGCGGCATGCCTGGTGTGCACGTGGCTGCCCGCCTACCGGATGCTGTTCACGAAGGCGGCACTGCGTCCCGGGGACACCGTGCTCGTCCAGGGTGCGGCGGGCGGGCTCTCCACCGCGCTGATCAGTCTGGCCGCGGCGAGCGGCCTGCGCACCTGGGTCACCGGCCGGTCCGCCGACAAGCGGGACCTGGCCCGCCGGCTGGGAGCGAGCGCCACGTTCGAACCGGGAGCAACGCTGCCCGAACAGGTCGACGCGGTCGTCGACAGCGTGGGAAAGGCGACGTGGATGCACTCGCTGCGCAGCGTCCGGCACGGCGGCACCGTGGTCGTCGCCGGTGCCACGACGGGAGATGTGCCCCCCGCCCGGCTGCATCGCATCTACTTCCACCAGGTCAATGTCGTGGGCTCCTTCAGCGGTACCCGCGAGGAGTACGGGCGACTGGTGACGTTGATGCGCACCACGGGCATCAGGCCGCTGGTGGACGACGTGCTGCCGATCCAGGAGGCGCGTGCGGCGCTCAAGCGACTCGCGGACGGGGACGTGCGGGGCAACCTCGTCCTCACCTGGTCCGAGGACGACCAGGTAGCCCAGTCCGAGGCGATGCGGCGCCTTTCCGTCTGGCTTCCCGGATGA	MKAVFASAPDPDDPLSAVVVGHRPEPEVPRGWVLVRVRAASLNHKDLWTLRGVGINRDQYPRILGCEAAGETPDGRRVVLYPLLDAPPGTSDETLVMPAAQLVGARPGTLAEYFVAPPESLLPVPDHLTWEEAACLVCTWLPAYRMLFTKAALRPGDTVLVQGAAGGLSTALISLAAASGLRTWVTGRSADKRDLARRLGASATFEPGATLPEQVDAVVDSVGKATWMHSLRSVRHGGTVVVAGATTGDVPPARLHRIYFHQVNVVGSFSGTREEYGRLVTLMRTTGIRPLVDDVLPIQEARAALKRLADGDVRGNLVLTWSEDDQVAQSEAMRRLSVWLPG	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	100.88	gnl|BL_ORD_ID|1039|hsp_num:0	1041			63	1005	ciprofloxacin; trimethoprim; chloramphenicol
BGC0001076.1|Liposidomycin_25 # 27868 # 29121 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.702	BGC0001076.1|Liposidomycin_25 	27868	29121	+	Loose	400	31.5722	Erm(43)	20.69	3003205	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAAGTGATCCGAGCGCAACGACAGGAGAGGGCCGCCGTCGCCGTGGTGCGTGAAGCCGGCGACGGCGCGGCCCTTCCGCCGTGCGACAGCCGCTTCCACTATGTTCCGCCGTGGCGGGCCTCCGCCCTGGAGACACTGGCCGAGGAGATCCTGCCCCAGGTCGCCGACATTCTGGCGCGCTACTCGGCCGTCGGCCGGCCGGACGACCTCCTCACCGCCGACGAGACGGCGACGCTGATCGGCGCGTGCGAGTATGTGCGGCTACGGGGTGGCGCCGACGGTTGCACCCTCGCCTTCCGCGGTCTGCCCGCGGAGCTGGCGGAGCATGCGCGGCGCGATCGCCTGACGGTGCGCGCGGCGCTGGAGTGCGTCGGCTGGTTCGACGCCAACCAGCGTTTCCTCACCGGCGTCGACATCGCACCCCGCCCGGGAACCGCTGCGCGGGCTTCCGACGGTGCGCTGTACGGACCGGAGCTGGCGCGGCGCTACGCCCCCGCACGGCAGGTGACCGAGCAGTTCAACGACGTCATACGCGGATTCGCCAAGGAGTTCCTCGGCTCGCTCCGCGTCCTGGAACTGGGCACCGGCACCGGCAGAGTGGGACGCAATGTCGCCACCCTCGCGGGCTCCTACGTCGGGATCGAGGCATCGCACGCGATGATCGAGGAGGGGCGCAAAGACGGCCTGGAGGTCCGGCACGGCGACATGATGGCGATGCCGTTCGACACGGGGTCGGCCGACGCGGTCATCGAGCACGAGAGCATCGACTTCTGCGCGGAGCCACTGTTGGCTGCCGCCGAAGTGGAACGAGTGCTGAGCCTGGGCGGCCGCTTCTACCGCATCGAACTGGAGGCCGCGCCCGCGGCCGGCGTCAGCCGTCTGCAGGAGGAGATCCCCGGACGGCTGGCCAAGATCTCCAGAGGGGTCTTCCCGTACTGGACCAAGGGACAACGCGGGCGCCTCCACGGATGGTTGCTGGGCCGCGGCTTTGCGCATCGCAGGATCGAGCTCGCGCGCTGGGAAGAGGTCCGGACCCTGCGCAACTGGCTCCAGGGCCTGGTGAACGCGAGCTATCCCTCGTTCTCGGGCGTCGACGAGCGGACGGCGCTTTCCGTCTGCGAGGAACTGGCACAGGAGGCCGCAATGGGGGACCTCGACACGCGGTCGCCGGGAGAGGTCGCCGTGGTCGTGCATCAGTACGAGATGGTCGACTGGTGCTGCCCGCGGCATCGCCCCGCCGGCACACCATGA	MKVIRAQRQERAAVAVVREAGDGAALPPCDSRFHYVPPWRASALETLAEEILPQVADILARYSAVGRPDDLLTADETATLIGACEYVRLRGGADGCTLAFRGLPAELAEHARRDRLTVRAALECVGWFDANQRFLTGVDIAPRPGTAARASDGALYGPELARRYAPARQVTEQFNDVIRGFAKEFLGSLRVLELGTGTGRVGRNVATLAGSYVGIEASHAMIEEGRKDGLEVRHGDMMAMPFDTGSADAVIEHESIDFCAEPLLAAAEVERVLSLGGRFYRIELEAAPAAGVSRLQEEIPGRLAKISRGVFPYWTKGQRGRLHGWLLGRGFAHRRIELARWEEVRTLRNWLQGLVNASYPSFSGVDERTALSVCEELAQEAAMGDLDTRSPGEVAVVVHQYEMVDWCCPRHRPAGTP	MNNKNPKDTQNFITSKKCINEILKNIIITADDNIVEIGTGKGHFTKALSKVVKSVIGVEIDKSLYYNLKKDSKLQDNIQLINQDILNFQFPDNKDYKIFGSIPYNISTEIIKKILYESKAEYNYLIVELGFAKRIQDKNKALSLLLLPKMDVEILKVIPNKYFHPKPKVESALILLKKHKPLISAKDEKNYQFFVYKWVNKEYKKLFTKNQFKKALKNANVQNLNKISKQQFISIFYSYKLFN	171.60	gnl|BL_ORD_ID|1422|hsp_num:0	1546			96	270	erythromycin; clindamycin; pristinamycin IA
BGC0001076.1|Liposidomycin_26 # 29146 # 29709 # 1 # ID=1_26;partial=00;start_type=TTG;rbs_motif=GGGA;rbs_spacer=7bp;gc_cont=0.647	BGC0001076.1|Liposidomycin_26 	29146	29709	+	Loose	375	89.3521	tmrB	32.97	3003059	protein homolog model	n/a	n/a	nucleoside antibiotic	reduced permeability to antibiotic	tunicamycin resistance protein	TTGCTCGTGTGGATCAACGGTCCTTTCGGGGCCGGTAAGTCGACTGTCACCGACGAACTGGTACGGACCGTCAAAAAGATCATCATGTTCGATCCGGAAGAGGTGGGGTTCCACCTACGGCAATGGGTGCCCATGCCGGCATCGGAGGACTTCCAGGACCTTGGGTGCTGGCGCGACCTCGTGGGACAGTCCTGTGCGGCCTTCGTCCGCCACTACCCGGATCATCTCGTGGTCGTGCCGATGACCGTGGTGAACGACGACTACCGGCGGGAGATCTTCGACATCATCCACAAGAGCACGGACGAGGTCCTGCACATCTGGCTGTCGGCCAGCCGGCAGACCCTCACCCGACGCATCACGGACCAGATCATGTTCCCGCATGATCCCGAGCGGGACGCCGGGGTGCGGGCCTGGCGACTTGCGCAGGTCGACGGCGCCATGGCCTGCGAGAAGCGACTGGGCCCGGACACGGTTGTTCTGCCGACGGATGACGCGAGCCCCTGGCAACTGGCCGAACGCATCCTCGCCGAGGCAGACCGGCACGCCCCTCGTGTGACGGGCTGA	MLVWINGPFGAGKSTVTDELVRTVKKIIMFDPEEVGFHLRQWVPMPASEDFQDLGCWRDLVGQSCAAFVRHYPDHLVVVPMTVVNDDYRREIFDIIHKSTDEVLHIWLSASRQTLTRRITDQIMFPHDPERDAGVRAWRLAQVDGAMACEKRLGPDTVVLPTDDASPWQLAERILAEADRHAPRVTG	MIIWINGAFGSGKTQTAFELHRRLNPSYVYDPEKMGFALRSMVPQEIAKDDFQSYPLWRAFNYSLLASLTDTYRGILIVPMTIVHPEYFNEIIGRLRQEGRIVHHFTLMASKETLLKRLRTRAEGKNSWAAKQIDRCVEGLSSPIFEDHIQTDNLSIQDVAENIAARAELPLDPDTRGSLRRFADRLMVKLNHIRIK	94.92	gnl|BL_ORD_ID|1654|hsp_num:0	1794			0	507	tunicamycin
